U.S. markets close in 2 hours 37 minutes

  • S&P 500

    3,619.90
    +110.46 (+3.15%)
     

  • Dow 30

    29,643.00
    +1,319.60 (+4.66%)
     

  • Nasdaq

    11,979.29
    +84.06 (+0.71%)
     

  • Russell 2000

    1,741.01
    +96.85 (+5.89%)
     

  • Crude Oil

    40.57
    +3.43 (+9.24%)
     

  • Gold

    1,858.00
    -93.70 (-4.80%)
     

  • Silver

    23.67
    -1.99 (-7.74%)
     

  • EUR/USD

    1.1815
    -0.0065 (-0.54%)
     

  • 10-Yr Bond

    0.9610
    +0.1410 (+17.20%)
     

  • GBP/USD

    1.3125
    -0.0025 (-0.19%)
     

  • USD/JPY

    105.5020
    +2.1410 (+2.07%)
     

  • BTC-USD

    15,211.17
    -60.93 (-0.40%)
     

  • CMC Crypto 200

    295.32
    -3.32 (-1.11%)
     

  • FTSE 100

    6,186.29
    +276.27 (+4.67%)
     

  • Nikkei 225

    24,839.84
    +514.61 (+2.12%)
     

What a COVID-19 vaccine would mean for the market, according to GS

Yahoo Finance’s Brian Sozzi, Myles Udland, and Julie Hyman discuss the timeline for a COVID-19 vaccine.

Video Transcript

MYLES UDLAND: But, Brian Sozzi, let's turn our attention back to ancient history. That'd be about 6:30 this morning looking through the weekend's dump of research notes that always come in on Monday mornings. And I know that the team over at Goldman Sachs writing about how crucial a vaccine could be for the future of the market. Of course, I guess the answer is here.

BRIAN SOZZI: Yeah, Myles. Far be it for me to pour cold water on this rip-your-face-off rally. But Goldman does note in a new research note, which should be noted, that came before news on Pfizer that you have to get this vaccine distributed. And if this vaccine is not distributed in the first quarter of 2021, Goldman thinks the S&P 500 can drop 11.4%.

The Russell 2000 small cap's down 17.2%. The NASDAQ could fall 9-- 9.3%. And really, It's great to have this news. You see PE multiples in-- inflated.

But this shot has to get into people's arms. And if it doesn't, you're still not going to take a cruise. You're not going to a AMC movie theater.

MYLES UDLAND: You know, Sozzi, I think it's interesting. On the back of that note, which-- I mean, I wouldn't call it consensus, but it's certainly something a lot of shops have written about, which is the risk to the downside here. It's interesting to see how much enthusiasm then there is on the upside.

I mean, it answers the question, was a positive vaccine priced in? The answer's clearly no. But it's-- it's interesting that it's no considering how many teams, you know, like Goldman, among others, were writing about the negative impacts if there had been [? a delay. ?]

BRIAN SOZZI: Yeah. I think this notion that the vaccine of any kind is priced in the market is getting very much shot down today. I've seen some firms say it's 50% priced in. But then what moves we're seeing in the markets today suggests it's just not the case.

MYLES UDLAND: Yeah. A lot of-- a lot of folks off sides there. And [? to ?] think, again, the travel, financials, and just pretty much everything that was unloved over the last couple of months getting a huge bid today. It'll be very interesting to see how that evolves over the next six hours of trading here on Wall Street.

Latest Stories

  • Biden Defeated Trump to Win the Election. Here’s How Much You Would Pay Under His Tax Plan.

    Former Vice President Biden has a detailed proposal that involves raising taxes on people with taxable income of more than $400,000—essentially targeting the top 1%. President Trump wants to keep the tax cuts that went into effect in 2018, which largely benefited top earners.

  • Biden And Trump React To Pfizer's Vaccine Update, Stock Market Rally: 'Great News!'

    Pfizer Inc (NYSE: PFE) and partner BioTech SE (NASDAQ: BNTX) reported interim analysis of a Phase 3 study on coronavirus candidate BNT 162b2.The trial showed a 90% efficacy rate at the seven-day mark after a second dose of the vaccine was applied.The trial began July 27 and the companies have enrolled 35,358 healthy volunteers in the trial.The overall market is surging on the news, with the SPDR S&P 500 Trust ETF (NYSE: SPY) up 5% to $366.29 in pre-market trading. Dow futures are set to soar 5%, or about 1,300 points.Related Link: Pfizer-BioNTech's COVID-19 Vaccine Is 90% Effective, EUA Filing Likely By Late NovemberJoe Biden's Reaction: In a statement, president-elect Joe Biden said he was informed last night of the study results. He reminds Americans that it could be months before approval and people have access to the vaccine."I congratulate the brilliant women and men who helped produce this breakthrough and to give us such cause for hope," he said.While staying positive, Biden also took the time to remind Americans to wear masks, practice social distancing and wash their hands."A mask remains a more potent weapon against the virus than the vaccine."Biden also said America is losing over 1,000 people a day to Covid-19 and cases are rising."Today's news is great news, but it doesn't change that fact," Biden said on wearing masks.Donald Trump's Reaction: President Donald Trump took to Twitter to say the following:> STOCK MARKET UP BIG, VACCINE COMING SOON. REPORT 90% EFFECTIVE. SUCH GREAT NEWS!> > -- Donald J. Trump (@realDonaldTrump) November 9, 2020Trump's first comment on the vaccine news was the impact it;s having on the stock market.The tweet from Trump broke a string of tweets from last night that shared Fox News videos that were labeled by Twitter as "this claim about election fraud is disputed."What's Next: Pfizer will continue safety data on the trial. The company plans on submitting the vaccine for emergency use authorization.Pfizer said it can produce up to 50 million vaccines in 2020 and up to 1.3 billion doses in 2021.Shares of Pfizer are up 14% to $41.65 in pre-market trading. Shares of BioNTech are up 25% to $114.88 in pre-market trading.See more from Benzinga * Click here for options trades from Benzinga * S&P 500 Rises 1% Each Of The Last 4 Days, Something Done Only 3 Times Since WWII * How The Betting Odds For Trump, Biden Fluctuated On Election Night(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Buy Fisker Stock Because the Price Could Double, Analyst Says

    Cowen analyst Jeffrey Osborne issued a Buy Rating on Monday. He sees shares hitting $22, up from Friday’s close of $10.86.

  • Stock market news live updates: Markets soar to record highs after upbeat vaccine data, Biden victory

    Stocks sailed to record highs Monday morning as traders took in promising data on a leading COVID-19 vaccine candidate as well as President-elect Joe Biden’s victory in the U.S. presidential election, ending a days-long nail-biter over which candidate would prevail in winning the White House.

  • Nio will be a ‘winner’ in EV market, analyst says

    Nio Inc. got a bullish endorsement from J.P. Morgan analyst Rebecca Wen, as she raised her stock price target on the belief the Shanghai-based company will be a "winner" in the electric vehicle market.

  • The Stock Market Is Soaring Because Pfizer’s Covid Vaccine Looks Like It Works

    The Dow Jones Industrial Average is soaring after (PFE)announced that its Covid-19 vaccine has a 90% efficacy rate. The Dow is up 1,100.88 points, or around 3.9%, following the announcement. The S&P 500 has also gained about 2.9% points, while the Nasdaq Composite has risen 1.2% as stay-at-home stocks get hit.

  • CEO: ‘It's almost impossible’ to find a pension plan that provides retirement income

    As pension plans fade, today’s investors may want to look to annuities to bridge the retirement gap, one expert said. 

  • McDonald's unveils its own meatless burger McPlant, a year after Beyond Meat test

    McDonald's enters the plant-based meat craze on its own.

  • COVID-19 vaccine must be released soon or stock market could drop more than 10%: Goldman Sachs

    Getting positive news on the COVID-19 front is essential to maintaining the stock market's post-election rally, Goldman Sachs believes.

  • Artificial Intelligence Stocks To Buy And Watch Amid Rising AI Competition

    When looking for the best artificial intelligence stocks to buy, identify companies using AI technology to improve products or gain a strategic edge, such as Microsoft, Netflix and Nvidia.

  • 2 ‘Strong Buy’ Stocks Poised for Growth

    Will the Democrats be detrimental to the stock market? No, the pros on Wall Street say.Although some investors have expressed concern about how the president-elect’s policies will affect stocks, as well as the impact of a potential “blue wave," which is a Democrat controlled White House, Senate and Congress, historically, analysts argue stocks have outperformed regardless of which political party controls the White House or Congress.Looking at data from the last 78 years, party control has had a limited effect on the broader S&P 500. Beginning in 1942, data demonstrates that Republican and Democratic majorities in the House and Senate have had little impact on share prices in the two-year period after an election. The same is true when comparing the number of party seats gained or lost in the House and Senate to stock prices for the S&P 500 during that period. Similar results are seen for the November to November cycle, which is a gauge of market sentiment to the election.Taking all of this into consideration, we used TipRanks’ database during our search for compelling plays. Locking in on two in particular, the platform identified two stocks that have received overwhelmingly bullish praise from the Street, enough to earn a “Strong Buy” analyst consensus.PulteGroup (PHM)Atlanta-based PulteGroup is the third-largest home construction company in the US, bringing in some $10 billion in annual revenues. The economic expansion seen during the last three years was good for the company, as growth in wages and expansion of the jobs market put money in people’s hands.The COVID-19 pandemic hit during the first quarter of the year, and PulteGroup did see earnings and revenues fall – but Q1 is historically the company’s slowest of the year, with the top and bottom lines both rising through Q4. Not only has PHM continued to follow that pattern, but quarterly results in 2020 have consistently beaten expectations and come in with year-over-year gains. In Q3, the most recently reported, EPS was $1.34, the highest in over two years, on revenues of $2.95 billion.Looking at the share price, PHM fell in February/March, along with the overall markets, but the stock has been gaining since. PHM hit bottom on March 23, and over the past seven and a half months has rebounded 148%.Covering PHM for RBC Capital, analyst Michael Dahl wrote, “While growth is currently all the rage, PHM’s balanced and return-driven model historically commands a stronger premium and we expect this to return in coming months as investors shift focus given the more difficult comps, community count trends, and inflationary pressures across the peer group. Importantly, PHM remains well positioned on land with>7 years controlled (53% owned, 47% optioned), which is a positive in a land-constrained and inflationary environment; coupled with pricing power, this should allow it to maintain GM >24%."Dahl rates the stock an Outperform (i.e. Buy) and his $53 price target suggests an upside of 22% for the coming year. (To watch Dahl’s track record, click here)Overall, PulteGroup holds a Strong Buy rating from the analyst consensus, based on 6 Buys and 2 Hold set in recent weeks. The stock’s $43.12 trading price and $55.67 average price target imply a one-year upside of 22.5%. (See PHM stock analysis on TipRanks)Dynatrace, Inc. (DT)With our second stock, we move into the world of AI. Dynatrace is an AI company offering cloud platforms that monitor and manage business software. The company's AI can handle the infrastructure on system architecture and cloud software, making it a one-stop tool for network manages seeking to minimize system strain.Dynatrace’s products have only grown in popularity during the coronavirus crisis. As white-collar offices make a strong shift toward remote work and virtual desktops, strong systems management has become a valuable commodity. Since bottoming out in mid-March, DT shares have showed investors a healthy rebound. The stock is up 90% since March lows.Covering this stock for Needham, Jack Andrews describes Dynatrace as the right company in the right niche at the right time.“[As] release cycles accelerate and services become hybrid, the demand for DT grows due to the increasing complexity of enterprise systems… DT's platform provides automation/AI to dynamically alert and monitor the topology of systems... We believe DT's product-fit may enable it to capture a large mix of these AI-driven enterprise workloads as it replaces incumbent tool and as customers expand to additional modules,” Andrews opined.In line with his comments, Andrews assigns DT a Buy rating, and his $50 price target indicates his confidence in a one-year upside of 61%. (To watch Andrews’ track record, click here)Overall, Wall Street loves this stock, earning a stellar analyst consensus rating, as TipRanks analytics demonstrate DT as a Strong Buy. Out of 11 analysts tracked by TipRanks in the last 3 months, 10 are bullish, while only 1 remains sidelined. With a return potential of nearly 34%, the stock's consensus target price stands at $50.36. (See DT stock analysis on TipRanks)To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

  • Oil Stocks Are Booming After Pfizer’s Covid Vaccine Announcement. What You Need to Know.

    The energy sector is booming, but refiners might be the first to see the good news impact their business.

  • 2020 Election Results: Biden's Win Should Boost These IRA, 401(k) Investments

    Joe Biden is President-Elect. Now check out these IRA and 401(k) investments that should get a boost from Biden's win.

  • Workhorse, Kandi Kick Off Heavy Slate Of EV Earnings With A Whimper

    Workhorse kicked off earnings from electric car stocks. But Workhorse stock fell as it gave weak fourth-quarter production guidance. Nikola is due.

  • Marijuana Stocks: Post-Election High Times Continue As Three Big Cannabis Producers Report Earnings Today

    The postelection rally for marijuana stocks continued, even as Aurora Cannabis continued to highlight industry woes. Canopy Growth beat views.

  • Zoom Shares Tumble on FTC Settlement, Pfizer Vaccine News

    Zoom shares, which have surged five-fold since the start of the year, fell more than 17% in early Monday trading after the online meeting group reached a privacy settlement with the Federal Trade Commission.

  • What will you do when the bull market tops out?

    Along with the rest of Wall Street, you will be caught up in the euphoria that accompanies a late-stage bull market. It’s been more than a month now since the stock market hit an all-time high, and it’s possible that the bull’s last gasp was registered then—and that a new bear market has already started. While that doesn’t mean that a new bear market has started, it also doesn’t mean that one hasn’t.

  • Electric Car Sales More Than Double In World's Biggest EV Market, But Tesla Lags

    Tesla trailed local Chinese players in a hot Chinese market for electric cars. But Tesla stock rose early Monday as it works on abuy point.

  • Cramer: Buy Airline Stocks On Rally Instead Of Cloud Stocks On Dips

    Jim Cramer shared his thoughts on what the potential COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) means for technology stocks that traded higher as stay at home plays.Stay-At-Home Stocks: Cramer said the S&P 500 and Dow are up the correct amount, but the Nasdaq futures are up too much. He said many of the companies in the Nasdaq don't benefit from the vaccine.Cramer said the vaccine coming is not good news for cloud stocks and not good for the big run-up in stay-at-home stocks.Some of the companies have risen this year as stay-at-home plays: "How many Nasdaq stocks can rally on this?"Cramer said some stocks are rallying on Joe Biden being elected and the potential positives from improved relations with China and that's okay.Related Link: Biden And Trump React To Pfizer's Vaccine Update, Stock Market Rally: Great News! Buy Airlines: Cramer said the stocks that are rallying like airlines and theme parks are making the right moves. Cramer said he would be "much more comfortable buying an airline stock up 10% than a cloud stock down 5%." Andrew Ross Sorkin asked Cramer if the stocks that are moving higher are worth buying since the timeline on approving a COVID-19 vaccine hasn't changed. Cramer said if you wait to buy, you'll miss the whole move" "Stocks trade in anticipation." Cramer said there are "many, many companies that benefit."Price Action: The SPDR S&P 500 Trust ETF (ARCA:SPY) is up 4% to $365.75 in pre-market trading. The Invesco QQQ ETF (NASDAQ: QQQ) is up 1% to $296.55.Airline stocks are rallying higher, with Southwest Airlines Co (NYSE: LUV) shares are up 15%, American Airlines Group (NASDAQ: AAL) shares are up 25% and JetBlue Airways Corporation (NASDAQ: JBLU) shares are up 18%.The U.S. Global JETS ETF (NYSE: JETS) is up 20% to $21.35 on Monday.See more from Benzinga * Click here for options trades from Benzinga * Biden And Trump React To Pfizer's Vaccine Update, Stock Market Rally: 'Great News!' * Kids Pushing Parents To Buy Electric Vehicles: Study(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Pfizer vaccine news sends AMC, travel and entertainment stocks on a tear on recovery hopes

    AMC and other theater stocks are soaring after Pfizer and BioNTech announced positive news about their vaccine candidate.